Dialysis industry news

Stories from the dialysis comunity across the globe.



Rockwell Medical, Inc. Analyst Rating Update - Insider Trading Report PDF Print

As many as 5 brokerage firms have rated Rockwell Medical Technologies (NASDAQ:RMTI) at 1.8. Research Analysts at Zacks have ranked the company at 3, suggesting the traders with a rating of hold for the short term. 1 analysts have rated it as strong sell. 4 analysts rated the company as a strong buy.

Rockwell Medical, Inc. (NASDAQ:RMTI): The mean short term price target for Rockwell Medical, Inc. (NASDAQ:RMTI) has been established at $16 per share. The higher price target estimate is at $26 and the lower price target estimate is expected at $4 according to 5 Analyst. The stock price is expected to vary based on the estimate which is suggested by the standard deviation value of $7.97 Rockwell Medical, Inc. (NASDAQ:RMTI) : On Thursday heightened volatility was witnessed in Rockwell Medical, Inc. (NASDAQ:RMTI) which led to swings in the share price. The shares opened for trading at $12.88 and hit $13.19 on the upside , eventually ending the session at $13.09, with a gain of 1.79% or 0.23 points. The heightened volatility saw the trading volume jump to 555,233 shares. The 52-week high of the share price is $13 and the company has a market cap of $657 million. The 52-week low of the share price is at $8.095 . Rockwell Medical, Inc., formerly Rockwell Medical Technologies, Inc., manufactures hemodialysis concentrate solutions and dialysis kits, and it sells, distributes and delivers these and other ancillary hemodialysis products primarily to hemodialysis providers in the United States, as well as internationally primarily in Asia, Latin America and Europe. Hemodialysis duplicates kidney function in patients with failing kidneys also known as End Stage Renal Disease (ESRD). ESRD is an advanced-stage of chronic kidney disease (CKD) characterized by the irreversible loss of kidney function. Its dialysis solutions (also known as dialysate) are used to maintain life, removing toxins and replacing nutrients in the dialysis patients bloodstream. As of December 31, 2011, it was licensed and was developing renal drug therapies. During the year ended December 31, 2011, it acquired an abbreviated new drug application (ANDA) for a generic version of an intravenous Vitamin-D analogue, calcitriol.

...

 
Lance boosts bill in Roxburty to improve care for chronic kidney dieease - New Jersey Hills PDF Print

MOUNT OLIVE TWP. – Rep. Leonard Lance, R-7, toured the Fresenius Medical Care (FMC) Kenvil Dialysis Facility on Friday, June 5 and later announced his support for legislation that would improve care for people with chronic kidney disease.

Lance is co-sponsor of the bill, the Chronic Kidney Disease Improvement in Research and Treatment Act of 2015, H.R. 1130, S. 598).

His 7th District includes the Morris County municipalities of Mount Olive, Chester, Chester Township, Dover, Long Hill Township, Mine Hill Township, Mount Arlington, Mount Olive Township, Netcong, Roxbury Township, Washington Township and Wharton.

The Chronic Kidney Disease Improvement in Research and Treatment Act supports improvements in the research, treatment and care of chronic kidney disease to benefit more than 636,000 Americans living with kidney failure which is known as end-stage renal disease, or ESRD, according to a statement.

Of those in kidney failure, 430,000 rely on life-sustaining dialysis care to survive, including 12,616 in New Jersey. The bill also would give patients with ESRD the choice to enroll in Medicare Advantage.

“The health care team at the FMC Kenvil Dialysis Facility is delivering high quality care to patients,” said Lance, a member of the Energy and Commerce Health Subcommittee. “As a cosponsor of the Chronic Kidney Disease Improvement in Research and Treatment Act I am working in Congress to ensure patients have access to the important services they need.”

Donna Buglisi, clinic manager for FMC Kenvil Dialysis Facility, said the proposed legislation supports greater patient choice, coordinated research programs, and economic stability for dialysis facilities.

“We believe this legislation would strengthen the delivery of care to dialysis patients including those we treat in Kenvil as well as the millions of Americans living with kidney disease,” Buglisi said.

Advocates have long stressed that federal policies are needed to provide patient choice and to ensure access to life-sustaining dialysis, to increase research into CKD, and to create stability in Medicare’s crucial ESRD program, the statement said.

The proposed legislation would improve patient outcomes through care coordination, expand access to traditionally underserved patient populations, and set the U.S. on the path towards a cure through efficiently managed and coordinated biomedical research, the statement said.

...

 
New centre for dialysis patients - TheChronicleHerald.ca PDF Print

Carol Betts couldn’t stop smiling when she walked into the bright, new dialysis unit at the QEII’s Halifax Infirmary on opening day in March. Knowing she would be spending 12 hours a week in the unit — likely for the rest of her life — the space was a welcoming site not only for her, but for all the other patients who will receive life-saving treatment with her.

“The old facilities are nice but they’re crowded,” says Carol, a grandmother who lives in Lower Sackville. “I don’t dread coming in now. It’s a lot nicer when you have a nice, bright unit to come to.”

Situated next to large windows, the new dialysis stations are not only brighter than those at the Dickson building at the QEII’s VG site, but are much larger and more comfortable for patients. They include televisions and QEII Wi-Fi access to help patients pass the time. Carol, who is in her third year of dialysis due to kidney disease, says having the option to watch a game show on television will make the dozen hours a week she spends on dialysis much easier.

The unit includes 12 dialysis stations - four new stations and eight that have been moved from the Dickson building. The additional stations mean more patients can be treated each week and the QEII can better meet the growing demand for dialysis in Nova Scotia.

Located near the Halifax Infirmary's Summer Street entrance is also good news for Carol, who uses a walker to get around. It’s also easier for her family members who drive her three times a week to dialysis appointments.

Patients who come to the QEII’s Halifax Infirmary from across the Maritimes to have inpatient procedures such as cardiovascular or orthopaedic surgery will be the biggest beneficiaries of the new unit, says Dr. Ken West, head of Nephrology.

“Until now, inpatients at the Halifax Infirmary needing dialysis treatment had to be transported to the VG site. This new unit allows for safer and more effective management of their dialysis,” says Dr. West.

The new unit means these patients won’t have to travel by ambulance to get their dialysis treatment, freeing up a lot of ambulatory services. Before the unit’s opening, as many as eight patients a day were transferred to the Dickson building for dialysis treatment.

Having eight more dialysis patients receive treatment daily because of the new unit is also good news for the province. “Nova Scotia has one of the highest rates of dialysis in the country,” says Dr. West.

Demand for dialysis services in Nova Scotia is growing at a rate of two to three per cent a year, he says, pointing to diabetes, cardiovascular disease and obesity as the primary causes of renal failure.

“We planned for the future,” says Anne Hiltz, director of the Pharmacy and Renal Program at the QEII, adding that there is room to expand the new unit.

Funded by the province’s Department of Health and Wellness, the new $3.5-million unit will treat 48 patients each week. The dialysis unit at the QEII’s Dickson building remains open with 34 treatment stations.

Currently, more than 450 patients receive dialysis treatment three times a week at the QEII and its satellite units in communities such as Berwick and Truro.

“Anything we can do to make the experience better is a good thing for our patients,” says Anne.

...

 
A Flag Raising Reminds Us to Give the Gift of Life - WSGW PDF Print

A Flag Raising Reminds Us to Give the Gift of Life
WSGW
Because of a degenerative kidney disease I was diagnosed with when I was 13, my renal cells grew increasingly damaged, until I was admitted to the hospital July 4, 2001, with End Stage Renal Disease, or ESRD. More simply put, kidney failure. I was on ...

...

 
Comfort Needs N26.9m for Urgent Dialysis, Transplant - Daily Times Nigeria PDF Print
FB_IMG_1429783593418

 

  • refused treatment in the United Kingdom

A former lecturer in the Department of English in Redeemer’s University where she was also the Head of Department (HOD) of the Theatre and Film Studies Department is in critical condition as you read this.

Worried by her deteriorating health condition, her siblings in the UK had invited her for a family vacation in the UK in the hope that spending time with family and friends abroad would help to refresh her.

But Awoyemi had collapsed on arrival in the UK, and her shocked relations made her undergo medical investigation.

On Friday the 13th of March 2015 at the London Royal Hospital, doctors told that her she had very high creatinine in her system and that ‘her kidneys have all gone.’

They recommended intervention of immediate dialysis as their findings revealed that Awoyemi has less than two (2) weeks to live if not on immediate dialysis. Furthermore, to live a normal life, she would need a kidney transplant.

She was immediately advised by the nephrologist to travel back to Nigeria to begin renal treatment and dialysis. Her inability to accommodate this devastating news caused her to almost go into depression but she rather sought solace in her Creator.

 

Refused treatment in the UK

Awoyemi went through difficult times as she was refused medical treatment in the United Kingdom because, unlike the rest of her siblings, she was not a registered British Citizen and so not entitled to the NHS care which she could use to start treatment.

In the midst of the preparation for her emergency travel back to Nigeria for treatment, she had two (2) life threatening experiences as she was almost lost to the cold hands of death.

Thank God  a little cousin who was just five years old noticed her aunty was taking too long in the toilet than usual and then went to check on her; all she could hear faintly was, “call your dad, call your dad.”

By the time her brother got to her, she had collapsed, found in a pool of her own blood and was unconscious in the bathroom. She was saved Thanks be to God she was revived by medics on duty at Queens Hospital, Romford, Essex, that night.

During these emergency crises, it was discovered that she had a hemoglobin level of 3.5% as they battled to save her life. Even the medical team where amazed at how she was able to survive with that level of blood.

They confirmed that if she had boarded a flight, she wouldn’t have made it to Nigeria alive as she was scheduled to the following day.

Now her siblings and the medical team were at cross-roads; she was certified unfit to travel and yet she needed treated in the UK, but wouldn’t be treated because Nigeria and the United Kingdom has no bi-lateral relationship.

In the course to save her life for the trip back to Nigeria, a considerate doctor had to delay her trip to go against administrative rules and put his profession on line to reduce her creatinine level that was 1338 to be fit to travel.

With God on her side, she made it back to Nigeria and was immediately admitted to a Specialist Hospital (Molly Specialist Hospital) in Ibadan before she was transferred to the University College Hospital (UCH) Ibadan.

Needs 81,000 Pounds to live

The Royal Free London had estimated Awoyemi’s dialysis in a month to be £6,500 at £500 per session of three (3) times in a week plus routine test. She would be on a bill of £6,500 every month till she gets a transplant. The transplant package at Royal Free London is £68,000 which we cannot afford. Friends and well-wishers advised reaching out to hospitals in India that can perform the kidney transplant at a lower cost.

So far, the Federal University of Technology Akure (FUTA) Community, her old students and her few remaining friends have been wonderful. But we need more help from the public and every well-meaning Nigerian to help save the life of Dr. Comfort Taye Arayela (Nee Awoyemi).

She has been on dialysis which does not come cheap and we are running out of funds. She needs an urgent kidney transplant within two weeks because dialysis is just a temporary means of survival and that is why the family is turning to the Nigerian public, institutions/corporate organisations, NGOs and individuals for financial help.

 

Dr. Comfort Taye Arayela, a single mother, is a trained linguist, an actress, a director and a senior lecturer who has lectured in some few Nigerian universities and colleges of education including the Federal University of Technology (FUTA), Akure and Redeemer’s University (RUN) in Nigeria. Her profession has brought her to teach many actors and actresses among whom are some Nollywood and Christian Drama Ministers. She has also crossed path with many theatre and film professors and lecturers as colleagues.

She is jnot a lazy person, neither is her family, but “we have sold all that we can call our own to save her life,” the family said.

“We are therefore appealing to the general public and anybody who has been part of her life directly (student, classmate, mentee, Sunday school pupil, drama/theatre crew, colleague, friend, family, etc.) or indirectly presently or in the past, to come to my aid.”

Please save her by donating through gofundme with this link http://www.gofundme.com/kidneyforcomfort or through her account:

Account Name: Comfort Taye Awoyemi, Bank: Access Bank, Account Number: 0031551081, Sort Code: 044150149

Account Name: Comfort Taye Arayela, Bank: First Bank, Account Number: 2027494488, Sort Code: 011151003.

Comments

comments

...

 
<< Start < Prev 161 162 163 164 165 166 167 168 169 170 Next > End >>

Page 166 of 4210
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.